Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Childhood Autism
NCT01780883Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Feb 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in Autism Spectrum Disorder (ASD), sponsored by CHU Rennes. Started Feb 2013; status: completed.
02
Drugs
melatonin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01780883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780883.